BeOne Medicines Ltd. Officer Files Form 144 Notice for 132 ADSs
BeOne Medicines Ltd.
Subscribe to track ONC
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Form 144 Notice of Proposed Sale ā¢ Company: BeOne Medicines Ltd. (CIK: 0001651308) ā¢ Insider: Titus Benjamin Ball (Officer) ā¢ Proposed Sale: 132 ADSs (~$46,973.52) ā¢ Approx. Date of Sale: 09/01/2026 ā¢ Broker: Morgan Stanley Smith Barney LLC ā¢ Significance: Low
Comprehensive Analysis
Executive Summary
On September 1, 2026, Titus Benjamin Ball, an Officer of BeOne Medicines Ltd., filed a Form 144 notice with the SEC indicating an intention to sell 132 American Depositary Shares (ADSs) with an aggregate market value of $46,973.52 (approx. $355.86 per share) through Morgan Stanley Smith Barney LLC.
Transaction Details
- Security Title: ADS
- Number of Units to Be Sold: 132
- Aggregate Market Value: $46,973.52
- Acquisition Source: Restricted Stock Vesting Under a Registered Plan on August 31, 2026 (132 ADSs from Issuer)
- Past 3 Months Sales History:
- June 11, 2026: 169 ADSs for gross proceeds of $43,466.56
- June 8, 2026: 136 ADSs for gross proceeds of $36,900.64
Market Impact & Significance
The trading significance of this filing is evaluated as Low. The transaction size represents a routine disposition following RSU vesting, amounting to a negligible fraction of the company's 57,914,782 outstanding units.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.